title: Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?
abstract: The plasma levels of several haemostatic and fibrinolytic parameters were measured before and after delivery in 61 hypertensive pregnant women of whom 22 developed preeclampsia, and compared to the results obtained in 42 normal pregnant women. In the two last weeks before delivery (D less than or equal to -15) tPA antigen, PAI-1 activity, vWF:Ag/FVIII:C ratio, ATIII activity and platelet count were found to be significantly different in the hypertensive pregnant women with and without preeclampsia. Combined all together, an association of three of these five parameters were found to be pathological (i.e.:tPA:Ag greater than or equal to 19 ng/ml, PAI-1 activity greater than or equal to 58 IU/ml, vWF:Ag/FVIII:C ratio greater than or equal to 2.6, ATIII activity less than or equal to 73%) in none of the hypertensive women without preeclampsia and in only 35% of the preeclamptic group. A positive correlation was demonstrated between vWF:Ag/FVIII:C ratio and tPA:antigen levels suggesting that both tPA and vWF:Ag could be considered as early indicators of a possible micro angiopathy occurring in preeclampsia. However, due to the high dispersion of the results, it appears that the investigated haemostatic and/or fibrinolytic criteria give only presumptive arguments before assigning risk for preeclampsia development among hypertensive pregnant women.
authors.affiliation: Laboratoire d'Hématologie, C.H.R.U. de Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Caron
authors.forename: J
authors.initials: J
authors.lastname: Goudemand
authors.forename: A
authors.initials: A
authors.lastname: Marey
authors.forename: D
authors.initials: D
authors.lastname: Beague
authors.forename: G
authors.initials: G
authors.lastname: Ducroux
authors.forename: F
authors.initials: F
authors.lastname: Drouvin
mesh_terms: D000293:Adolescent; D000328:Adult; D000941:Antigens / Q000378:metabolism; D000990:Antithrombin III / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D005342:Fibrinolysis / Q000502:physiology*; D006487:Hemostasis / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications; D010976:Platelet Count; D011225:Pre-Eclampsia / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D011237:Predictive Value of Tests; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood*; D011486:Protein C / Q000378:metabolism; D012307:Risk Factors; D014841:von Willebrand Factor / Q000276:immunology
chemical_list: D000941:Antigens; D011486:Protein C; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; D000990:Antithrombin III; D005169:Factor VIII